These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8173699)

  • 1. Differential effects of ACE inhibitors and vasodilators on renal function curve in patients with primary hypertension.
    Fliser D; Nowack R; Wolf G; Ritz E
    Blood Press; 1993 Dec; 2(4):296-300. PubMed ID: 8173699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibition and AT1 receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with human renin and angiotensinogen genes.
    Mervaala E; Dehmel B; Gross V; Lippoldt A; Bohlender J; Milia AF; Ganten D; Luft FC
    J Am Soc Nephrol; 1999 Aug; 10(8):1669-80. PubMed ID: 10446934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients.
    Velussi M; Brocco E; Frigato F; Zolli M; Muollo B; Maioli M; Carraro A; Tonolo G; Fresu P; Cernigoi AM; Fioretto P; Nosadini R
    Diabetes; 1996 Feb; 45(2):216-22. PubMed ID: 8549868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of single and consecutive doses of cilazapril and its depressor effects in patients with essential hypertension.
    Shionoiri H; Gotoh E; Miyakawa T; Takasaki I; Oda H; Ueda S; Kaneko Y
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):269S-273S. PubMed ID: 2970854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of antihypertensive therapy with cilazapril and hydrochlorothiazide on the stiffness of the aorta.
    Breithaupt-Grögler K; Leschinger M; Belz GG; Butzer R; Erb K; de May C; Sinn W
    Cardiovasc Drugs Ther; 1996 Mar; 10(1):49-57. PubMed ID: 8723170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin-converting enzyme inhibition on renal sodium handling after furosemide injection.
    Nowack R; Fliser D; Richter J; Horne C; Mutschler E; Ritz E
    Clin Investig; 1993 Aug; 71(8):622-7. PubMed ID: 8219659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-adrenergic and angiotensin II pressor sensitivity in hypertensive patients treated with an angiotensin-converting enzyme inhibitor.
    Rosendorff C; Patton J; Radford HM; Kalliatakis B
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S105-9. PubMed ID: 1382157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats.
    Matsumoto K; Morishita R; Moriguchi A; Tomita N; Yo Y; Nishii T; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1999 Aug; 34(2):279-84. PubMed ID: 10454454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure.
    Uusitupa M; Korhonen M; Litmanen H; Niskanen L; Väisänen S; Rauramaa R
    J Hum Hypertens; 1996 May; 10(5):319-26. PubMed ID: 8817406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension.
    Himmelmann A; Hansson L; Hansson BG; Hedstrand H; Skogström K; Ohrvik J; Furängen A
    Blood Press; 1995 Mar; 4(2):85-90. PubMed ID: 7599759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure.
    Kloke HJ; Huysmans FT; Wetzels JF; Sluiter HE; Kleinbloesem CH; Koene RA
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):289S-296S. PubMed ID: 2527541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
    Sánchez RA; Traballi CA; Barclay CA; Gilbert HB; Muscará M; Giannone C; Moledo LI
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study on the short-term effects of angiotensin converting enzyme inhibitors (Lopirin, SQUIBB and Tensiomin), and dihydralazine in chronic cardiac failure.
    Dékány M; Bányai F; Antalóczy Z
    Acta Physiol Hung; 1988; 72 Suppl():93-110. PubMed ID: 3075406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension.
    Huang SS; Wu TC; Lin SJ; Chen JW
    Circ J; 2009 Dec; 73(12):2282-7. PubMed ID: 19789415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal or impaired renal function.
    Shionoiri H; Gotoh E; Sugimoto K; Takasaki I; Minamisawa K; Ishii M
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):283S-287S. PubMed ID: 2527540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salt sensitivity of hypertension and responses to angiotensin converting enzyme inhibition with benazepril.
    Moore TJ; Rich G; McKnight JA; McCullough M; Hollenberg NK
    Am J Hypertens; 1996 Jan; 9(1):54-60. PubMed ID: 8834707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and haemodynamic effects of the angiotensin converting enzyme inhibitor cilazapril in hypertensive patients with normal and impaired renal function.
    Kloke HJ; Ambros RJ; Van Hamersvelt HW; Wetzels JF; Koene RA; Huysmans FT
    Br J Clin Pharmacol; 1996 Nov; 42(5):615-20. PubMed ID: 8951193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibition causes deterioration in renal function in one-kidney Goldblatt hypertensive rats with and without renal arterial stenosis.
    Huang WC; Wu JN; Jin JS
    Clin Exp Pharmacol Physiol; 1992 Oct; 19(10):695-703. PubMed ID: 1424298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
    Kohzuki M; Kanazawa M; Liu PF; Kamimoto M; Yoshida K; Saito T; Yasujima M; Sato T; Abe K
    J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term renal preservation in essential hypertension. Angiotensin converting enzyme inhibition is superior to beta-blockade.
    Himmelmann A; Hansson L; Hansson BG; Hedstrand H; Skogström K; Ohrvik J; Furängen A
    Am J Hypertens; 1996 Sep; 9(9):850-3. PubMed ID: 8879340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.